Covid-19: Covaxin effective against Brazilian variant, says ICMR | News – Times of India Videos

May 03, 2021, 06:13PM ISTSource:

ICMR has said that the indigenously developed Covaxin is capable of fighting the Brazilian variant. With this the vaccine, developed by the Indian Council of Medical Research (ICMR) in collaboration with Bharat Biotech, is capable of fighting some of the major variants of concern (VoC), currently in circulation in the country. Covishield, another Covid-19 vaccine currently available in India, was also found to neutralise the double mutant. Earlier, Covaxin was found to fight the UK variant, B117, and the so-called double mutant of Maharashtra, B1617.


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.